Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome

27Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Selenium is a trace element that plays a critical role in physiological processes and cancer prevention, whose functions may be through its effects on selenium-containing proteins. Selenium-binding protein 1 (SBP1) is a member of an unusual class of selenium-containing proteins that may function as a tumor suppressor in multiple cancer types and whose levels have been shown to be lower in cancers as compared to corresponding normal tissues. This review is intended to summarize recent advances in gaining an understanding of the significance of SBP1 in carcinogenesis, and suggest that SBP1 could be developed as a potential biomarker for cancer progression and prognosis. © 2013 Yang and Diamond; licensee BioMed Central Ltd.

Cite

CITATION STYLE

APA

Yang, W., & Diamond, A. M. (2013, March 1). Selenium-binding protein 1 as a tumor suppressor and a prognostic indicator of clinical outcome. Biomarker Research. BioMed Central Ltd. https://doi.org/10.1186/2050-7771-1-15

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free